Breakthroughs in cancer research don’t usually begin with multi-million-dollar grants — they start with one bold idea. See how pilot funding has helped HICCC researchers take risks to shape the future of cancer treatments. #NationalCancerResearchMonth www.cancer.columbia.edu/news/idea-im...

Great write-up from @columbiacancer.bsky.social "A cellular wrong turn in blood cancer” on our paper from @cohesinlab.bsky.social published in @bloodjournal.bsky.social . 🔑Key point: STAG2 doesn’t change how much GATA1 there is—it changes where it can act. www.cancer.columbia.edu/news/cellula...

Super proud of my postdoc, Alvaro Curiel-Garcia @alvarocuriel.bsky.social for his Rising Star lecture at #AACR26. Alvaro has a Nature Genetics cofirst author paper in press, and another 1st author manuscript that is in revision, also at Nature Genetics. He's on the job market folks!

Millions of women are finding out they have dense breasts, but what to do next still leaves many uncertain. In this Q&A, Julia McGuinness & Elena Elkin explain why breast density alone isn’t enough to guide breast cancer screening decisions: www.cancer.columbia.edu/news/beyond-...

HICCC is AACR-bound! ✈️🔬 Take a look at our @theaacr.bsky.social 2026 roundup and mark your calendar: our research will be shared in 40+ sessions and presentations. Check out our major symposia highlights from this year’s meeting, below: www.cancer.columbia.edu/news/roundup...

Julia McGuinness, MD has been awarded a $100,000 @preventcancer.org grant to study whether weight-loss treatments lead to mammogram changes that signal lower breast cancer risk. 👏 Learn more. preventcancer.org/news/prevent...

Big changes to U.S. nutrition guidance are here with the HHS new “inverted” food pyramid. For Cancer Prevention Month, @columbiamed.bsky.social dietitian Sabrina Oliver breaks down how to view the guidelines through a cancer-prevention lens. 🥦🥩 www.cancer.columbia.edu/news/does-ne...

‼️After a decade+ of research, @columbiamed.bsky.social scientists led by Wei Gu have discovered the natural mechanism behind a novel form of cell death called ferroptosis. Read about this work in @cellpress.bsky.social www.cancer.columbia.edu/news/ironing...

New research led by Andrea Califano, Dr, unveils a framework to decode hundreds of thousands of previously “uninterpretable” cancer mutations— helping clinicians prioritize more effective treatments and avoid unnecessary ones. @biohub.org 🔗 www.cancer.columbia.edu/news/turning...

Sarcoma is rare, but inequities in life-saving care are widespread in underserved communities. Read how Wakenda Tyler, MD, is pushing the field to confront disparities, like higher amputation and mortality rates. #BlackHistoryMonth @columbiamed.bsky.social www.cancer.columbia.edu/news/wakenda...

💭 Do GLP-1s raise, lower, or not affect cancer risk? As GLP-1 drugs surge in popularity, so have questions about their safety, especially around cancer. Based on current evidence, the answer is reassuring and increasingly hopeful. ⤵️ www.cancer.columbia.edu/news/glp-1-w...

A national clinical trial open at @columbiamed.bsky.social is testing a new precision medicine approach developed by Rob Wechsler-Reya, PhD- directly testing how each patient’s tumor cells respond to different drugs, rather than testing genetics alone. → www.cancer.columbia.edu/news/q-testi...

The 2025 issue of Pathways to a Cure is here! See how HICCC is driving breakthroughs in cell therapy, AI precision prevention, and early-onset cancers—while expanding access to world-class care at Columbia. Read now ⬇️ pubs.cancer.columbia.edu/reports/2025...

Engineering bispecific exosome activators of T cells to target immune checkpoint inhibitor-resistant metastatic melanoma - @columbiacancer.bsky.social go.nature.com/496Ins7

HICCC is presenting at #ASH2025! Follow along for highlights on research from Columbia at this year’s American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando. ↘️Be sure to tag us to be promoted! View more: mailchi.mp/cumc/hiccc-w...

The first FDA-approved liquid biopsy test for cancer screening is here - and raising big questions about how it could transform cancer care. HICCC’s Dr. Chin Hur weighs in. More in this Q&A 👉 cancer.columbia.edu/news/what-kn...

The Spring/Summer issue of Accelerations is here! We're spotlighting momentum— discover what's next in cancer research, breakthroughs in drug discovery, and progress in pancreatic cancer. Read the issue below. hiccc-accelerations.onpubli.com/Spring-Summe...

Getting through the blood-brain barrier remains a huge challenge in brain tumor treatment. Read how HICCC researchers Elisa Konofagou & Stergios Zacharoulis are using #soundwaves to open it just long enough to deliver therapy. engineering.columbia.edu/about/news/t...

Uterine cancer is one of the few cancers with rising incidence and mortality. A new @columbiamed.bsky.social study led by HICCC’s Jason D. Wright projects a sharp increase over the next 30 years—disproportionately impacting Black women. Read more: www.cuimc.columbia.edu/news/uterine...

Last week, we celebrated the official launch of the Center for Innovation in Imaging Biomarkers and Integrated Diagnostics (CIMBID) at Columbia. @columbiamed.bsky.social Catch the highlights and recordings below. @columbiaimaging.bsky.social columbiaradiology.org/news/columbi...

Today marks Day 1 of the second cohort of the 2025 IICD Intensive Workshop. We’re thrilled to welcome a new group of graduate students and postdocs for a week of immersive learning! #CancerResearch #STEMeducation @elhamazizi.bsky.social @columbiamed.bsky.social @columbiacancer.bsky.social

Tattoos last forever-but do they come with health risks that stick around just as long? 💭 HICCC's Dr. Mariam El-Ashmawy breaks down what early research shows —and what you can do to protect your skin with or without tattoos. www.cancer.columbia.edu/news/tattoos...

The SRP interns had a great seminar with Dr. @brentstockwell.bsky.social Thank you, Dr. Stockwell, for sharing your career path and research with our summer interns! 🔬✨ #CancerResearch #STEMeducation #IICDSR #SummerInternship @columbiacancer.bsky.social

Highlights from HICCC's 3rd Annual Clinical Trials Day at @columbiamed.bsky.social 🏥👏 Thank you to everyone who joined us last week to learn about the urgent need for broader participation in #ClinicalTrials

View today's final HICCC #ASCO2025 daily roundup, below!

View today's HICCC #ASCO2025 daily roundup, below!

View today's HICCC #ASCO25 daily research roundup, below!

View today's HICCC #ASCO2025 daily roundup, below!

Headed to #ASCO2025 ?! 🔬✈️ Stay tuned for daily HICCC sessions, spotlight lectures, and late breaking research at @ascocancer.bsky.social ! Be sure to add our sessions to your meeting planner, and tag us to be featured! 📸 meetings.asco.org/meetings/202...

Nearly everything we know about cancer started in a clinical trial. But what are clinical trials really like? 💭 🔬 Read on for answers to more common questions—and misconceptions—about cancer #clinicaltrials www.cancer.columbia.edu/news/answeri...

Cancer research is a team effort. 🌎🔬This #CancerResearchMonth the HICCC thanks everyone who makes life-changing breakthroughs possible at Columbia. @columbiamed.bsky.social

Neurosurgeons at NYP / @columbiamed.bsky.social / @weillcornell.bsky.social are studying a new ultrasound tech to help drugs reach glioblastoma tumors. The SONOBIRD trial tests a device that disrupts the blood-brain barrier. More from Dr. Brian Gill below. 🧠 💊 nyp.org/advances/art...

🗓️🥼 @columbiamed.bsky.social 2025 Clinical Trials Day brings together experts, advocates, and community leaders to explore how equity in clinical research can transform lives and strengthen communities—both locally and globally. Register below! bit.ly/43DVFsn

👏Congratulations to HICCC Deputy Director, @drdawnhershman.bsky.social -this year’s recipient of the @ascocancer.bsky.social Karnofsky Memorial Award!

Mark your calendars! 🗓️ Join the HICCC and the Columbia Initiative in Cell Engineering and Therapy for "New Advances in Cancer Cell Therapy", a mini-symposium in ft. a keynote address from Michel Sadelain, MD, PhD. Register below to save your spot. bit.ly/4kk913F

Patient Symptoms and Disease Features Guide Pirtobrutinib Use in R/R #CLL. @columbiacancer.bsky.social #oncology www.onclive.com/view/patient...

Excited to announce our annual New York City Edward P. Evans MDS Centers Symposium across @mskcancercenter.bsky.socia & @columbiacancer.bsky.social. This year to be held at @mskcancercenter.bsky.socia. See this flyer below and register here: forms.fillout.com/t/1wX3dGmym4us

🧬May is National Cancer Research Month—a time to celebrate progress and the people behind it. Watch how @columbiacancer.bsky.social is making strides toward better, more equitable cancer care: youtu.be/V9uz3ZhG4D8 #CancerResearchMonth #ColumbiaCancer

Thanks to a $10M grant from @themarkfdn.bsky.social and Torrey Coast Foundation, the new Mark Foundation Center for Lineage Plasticity—co-led by HICCC and @mskcancercenter.bsky.social—will accelerate research on cellular plasticity and cancer progression. www.cuimc.columbia.edu/news/columbi...

🔬 During #CancerResearchMonth, we’re spotlighting @brentstockwell.bsky.social, exploring ferroptosis as a powerful way to eliminate aggressive cancers. His latest work links diet and cancer treatment: bit.ly/4iNEWc5 @columbiacancer.bsky.social @columbiamed.bsky.social @columbiasysbio.bsky.social

HICCC's FINAL #AACR25 Daily Roundup: View our research sessions happening today. cancer.columbia.edu/news/roundup...

This year’s 11 NextGen Stars will share their findings on cancer cartography, the dark proteome, cancer-resistant tissues, and more at #AACR25. Learn more about their work and its future implications on the #AACRBlog: www.aacr.org/blog/2025/04...

#AACR2025 Daily Roundup: View HICCC's research sessions happening today! @theaacr.bsky.social cancer.columbia.edu/news/roundup...

And now for postdoc #2 at #aacr2025, our very own Dr. Marie Hasselluhn! @columbiacancer.bsky.social

Big day today at #aacr2025! @alvarocuriel.bsky.social is presenting his work on BMAL2, a master regulator of PDAC hypoxic response (poster 2570) and Dr. Marie Hasselluhn is presenting her work on role of CAF/myeloid crosstalk in PDAC immunosuppression in PDAC (poster 1501). Come check them out!

#AACR2025 Daily Roundup: View HICCC's research sessions happening today! cancer.columbia.edu/news/roundup...

#AACR2025 Daily Roundup: View HICCC's research sessions happening today. www.cancer.columbia.edu/news/roundup...

Kicking off #AACR2025 Day 1! Today, HICCC will present on lineage plasticity, nuclear topology, gene regulation, and more. See the highlights below. @theaacr.bsky.social Check out our full roundup -https://cancer.columbia.edu/news/roundup-hiccc-aacr-2025

If you’re at @theaacr.bsky.social don’t miss today’s session on 3D Topology & Cancer featuring giants of the field: Jane Skok @nyulangone.bsky.social & Brad Cairns @utah.edu Imposter syndrome at an all time high! 😬 Proud to represent @cohesinlab.bsky.social @columbiacancer.bsky.social #AACR25

On my way to #aacr2025 in Chicago, can't wait to see my many friends and colleagues who will be there. Please check out posters from my postdocs @alvarocuriel.bsky.social and Marie Hasselluhn!